Horizon Therapeutics PLC (HZNP):企業の財務・戦略的SWOT分析

◆英語タイトル:Horizon Therapeutics PLC (HZNP) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1643
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Horizon Therapeutics PLC (HZNP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Horizon Therapeutics PLC (Horizon Therapeutics) formerly known as Horizon Pharma plc, is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The company’s marketed products include Actimmune, Buphenyl, Duexis, Krystexxa, Pennsaid 2%, Procysbi, Quinsair, Ravicti, Rayos and Vimovo. Horizon Therapeutics provides products and services to patients and healthcare professionals in the US. The company operates through offices in the US, Switzerland, the Netherlands and Germany. Horizon Therapeutics is headquartered in Dublin, Ireland.

Horizon Therapeutics PLC Key Recent Developments

Feb 28,2020 Horizon and Willis Tower elevate the need for rare disease innovation on Rare Disease Day
Feb 26,2020 Horizon Therapeutics reports fourth-quarter and full-year 2019 financial results; announces full-year 2020 guidance
Jan 28,2020 Horizon Therapeutics announces significant expansion and relocation of U.S. Operations
Jan 24,2020 Horizon Therapeutics announces changes in research and development organization

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Horizon Therapeutics PLC – Key Facts
Horizon Therapeutics PLC – Key Employees
Horizon Therapeutics PLC – Key Employee Biographies
Horizon Therapeutics PLC – Major Products and Services
Horizon Therapeutics PLC – History
Horizon Therapeutics PLC – Company Statement
Horizon Therapeutics PLC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Horizon Therapeutics PLC – Business Description
Business Segment: Inflammation
Overview
Performance
Business Segment: Orphan and Rheumatology
Overview
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: United States
Performance
Horizon Therapeutics PLC – Corporate Strategy
Horizon Therapeutics PLC – SWOT Analysis
SWOT Analysis – Overview
Horizon Therapeutics PLC – Strengths
Horizon Therapeutics PLC – Weaknesses
Horizon Therapeutics PLC – Opportunities
Horizon Therapeutics PLC – Threats
Horizon Therapeutics PLC – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Horizon Therapeutics PLC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Horizon Therapeutics PLC, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Horizon Therapeutics PLC, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 28, 2020: Horizon and Willis Tower elevate the need for rare disease innovation on Rare Disease Day
Feb 26, 2020: Horizon Therapeutics reports fourth-quarter and full-year 2019 financial results; announces full-year 2020 guidance
Jan 28, 2020: Horizon Therapeutics announces significant expansion and relocation of U.S. Operations
Jan 24, 2020: Horizon Therapeutics announces changes in research and development organization
Jan 13, 2020: Horizon Therapeutics increases peak U.S. annual net sales expectations for key growth drivers; provides update on several pipeline programs
Nov 22, 2019: Horizon Therapeutics opens new manufacturing and R&D facility in South San Francisco
Nov 21, 2019: Horizon Therapeutics launches new online community connecting people living with thyroid eye disease and urging them to “Listen to Your Eyes”
Nov 14, 2019: FORTUNE and Great Place to Work name Horizon Therapeutics to Best Workplaces for Parents List
Nov 06, 2019: Horizon Therapeutics reports strong third-quarter 2019 results
Nov 05, 2019: Horizon Therapeutics brings gout-kidney link into focus during American Society of Nephrology (ASN) Kidney Week 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Horizon Therapeutics PLC, Key Facts
Horizon Therapeutics PLC, Key Employees
Horizon Therapeutics PLC, Key Employee Biographies
Horizon Therapeutics PLC, Major Products and Services
Horizon Therapeutics PLC, History
Horizon Therapeutics PLC, Subsidiaries
Horizon Therapeutics PLC, Key Competitors
Horizon Therapeutics PLC, Ratios based on current share price
Horizon Therapeutics PLC, Annual Ratios
Horizon Therapeutics PLC, Annual Ratios (Cont...1)
Horizon Therapeutics PLC, Annual Ratios (Cont...2)
Horizon Therapeutics PLC, Interim Ratios
Horizon Therapeutics PLC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Horizon Therapeutics PLC, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Horizon Therapeutics PLC, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Horizon Therapeutics PLC, Performance Chart (2015 - 2019)
Horizon Therapeutics PLC, Ratio Charts
Horizon Therapeutics PLC, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Horizon Therapeutics PLC, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Horizon Therapeutics PLC (HZNP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Bright Food (Group) Co Ltd:企業のM&A・事業提携・投資動向
    Bright Food (Group) Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bright Food (Group) Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Tractebel Engineering S.A.:企業の戦略的SWOT分析
    Tractebel Engineering S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • IBIDEN Co Ltd (4062):企業の財務・戦略的SWOT分析
    IBIDEN Co Ltd (4062) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Encompass Health Corporation:企業の戦略・SWOT・財務情報
    Encompass Health Corporation - Strategy, SWOT and Corporate Finance Report Summary Encompass Health Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Worldpay Group Ltd:企業の戦略・SWOT・財務分析
    Worldpay Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Worldpay Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lonrho Ltd:企業のM&A・事業提携・投資動向
    Lonrho Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lonrho Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Hill-Rom Holdings Inc (HRC):企業の財務・戦略的SWOT分析
    Hill-Rom Holdings Inc (HRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • China Haisheng Juice Holdings Co Ltd:戦略・SWOT・企業財務分析
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Mustek Limited (MST):企業の財務・戦略的SWOT分析
    Mustek Limited (MST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析
    Emerald Expositions, Inc. (EEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Warburg Pincus LLC:戦略・SWOT・企業財務分析
    Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report Summary Warburg Pincus LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sarawak Energy Bhd:企業の戦略的SWOT分析
    Sarawak Energy Bhd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Bengal Energy Ltd (BNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets in Australia’s Cooper Basin and India’s Cauvery Basin. The company holds interest in Toooko …
  • Interprotein Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Interprotein Corp (Interprotein) is a drug development company that develops active modulators for protein-protein interaction (PPI) targets. The company offers products such as IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E …
  • SREI Infrastructure Finance Ltd:企業のM&A・事業提携・投資動向
    SREI Infrastructure Finance Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SREI Infrastructure Finance Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • BLS AG:企業の戦略・SWOT・財務情報
    BLS AG - Strategy, SWOT and Corporate Finance Report Summary BLS AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Transportadora De Gas Del Sur S.A.
    Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report Summary Transportadora De Gas Del Sur S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • AGL Energy Ltd (AGL):石油・ガス:M&Aディール及び事業提携情報
    Summary AGL Energy Limited (AGL) is an integrated energy company that owns, operates and develops energy assets and provides natural gas, electricity, solar photovoltaic solutions and related products and services. The company’s power generation portfolio includes coal, gas, hydro, wind, solar, land …
  • Mount Tam Biotechnologies Inc (MNTM)-製薬・医療分野:企業M&A・提携分析
    Summary Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that focuses on the development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamyci …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆